guanylyl-(3--5-)-guanosine and 3--deamino-3--(3-cyano-4-morpholinyl)doxorubicin

guanylyl-(3--5-)-guanosine has been researched along with 3--deamino-3--(3-cyano-4-morpholinyl)doxorubicin* in 1 studies

Other Studies

1 other study(ies) available for guanylyl-(3--5-)-guanosine and 3--deamino-3--(3-cyano-4-morpholinyl)doxorubicin

ArticleYear
In vitro transcription analysis of DNA adducts induced by cyanomorpholinoadriamycin.
    Biochemistry, 1992, Oct-13, Volume: 31, Issue:40

    The reaction of cyanomorpholinoadriamycin (CMA) with DNA results in the formation of sequence-specific complexes with DNA. These complexes were revealed as blocked transcripts in an in vitro transcription assay--of 14 high-intensity blockages detected in the 120 bp probed in this assay, 12 were prior to GpG or CpC sequences. Slow read-through past the first few sites exhibited first-order kinetics, with half-lives of 25-200 min. Bidirectional transcription footprinting revealed nine high-intensity sites, eight of which were defined by a GpG element (nontemplate strand). Reaction of CMA with single-strand DNA, followed by a primer-extension assay, revealed four major blockages all of which were at GpG sites on the initial single-strand DNA. From a combination of these three experimental approaches, it appears that CMA yields dominantly intrastrand cross-links between adjacent guanine residues. Since CMA is also known to form interstrand cross-links, these appear to occur at GpC sequences but are minor in comparison to the extent of formation of intrastrand cross-links.

    Topics: Alkylation; Base Sequence; Cross-Linking Reagents; Dinucleoside Phosphates; DNA; DNA Fingerprinting; DNA, Single-Stranded; Doxorubicin; Kinetics; Molecular Sequence Data; Transcription, Genetic

1992